Clinical Trial Update: PMCF Study of the CE-marked Drainova® ArgentiC Catheter

View source ↗

Summary

This PMCF study of the CE-marked Drainova ArgentiC Catheter by ewimed GmbH has completed. It evaluated its use for pleural effusion (including malignant pleural…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Malignant Ascites
• Malignant Pleural Effusion
• Pleural Effusion

Drugs mentioned

• Drainova ArgentiC Catheter

Snippet

Sponsor: ewimed GmbH | Conditions: Pleural Effusion, Pleural Effusion, Malignant | Status: COMPLETED